Table 1.
Guideline-consistent | Too early | Missed | ||||
---|---|---|---|---|---|---|
Based on clinical recommendations from 1995–20001 (2002 NSFG) |
Had Pap test | Had Pap test | No Pap test | |||
• | Ages 15–17 and sexually active |
• | Ages 15–17 and not sexually active |
• | Ages 15–17 and sexually active |
|
• | Ages 18–29, regardless of sexual activity status |
• | Ages 18–29 | |||
No Pap test | ||||||
15–17 and not sexually active |
||||||
Based on clinical recommendations from 2002–2003 2 (2006–2008 NSFG) |
Had Pap test | Had Pap test | No Pap test | |||
• | Ages 15–20 and ≥ 3 years from first intercourse |
• | Ages 15–20 and <3 years from first intercourse or never had sex |
• | Ages 15–20 and ≥ 3 years from first intercourse |
|
• | Ages 21–29 | • | Ages 21–293 | |||
No Pap test |
||||||
• | Ages15–20 and < 3 years from first intercourse or never had sex |
ACOG: Recommendations on frequency of Pap test screening. American College of Obstetrics & Gynecology Opinion Committee on Gynecologic Practice; 1995. USPSTF: U.S. Preventive services task force guide to clinical preventive services. 2nd ed. Washington, DC: Office of Disease Prevention and Health Promotion; 1996. ACS: American cancer society guidelines the early detection of cancer; 2000.
ACOG: Practice Bulletin No. 45: Cervical cytology screening; 2003. USPSTF: Screening cervical cancer, recommendations and rationale; 2003. http://www.uspreventiveservicestaskforce.org/3rduspstf/cervcan/cervcanrr.htm ACS: American cancer society guideline for the early detection of cervical neoplasia and cancer; 2002.
Missed screening for 21–29 year olds in 2006–2008 was defined according to ACOG and USPSTF recommendations for conventional cytology. Some women in this category could have received guideline-consistent screening based on ACS guidelines for liquid-based cytology every other year.